Table 2 The median TSH level in participants without known thyroid dysfunction (n = 3638) according to Thyroid Antibodies Statusa
From: The prevalence of thyroid dysfunction in Jordan: a national population-based survey
Age | Regardless of Thyroid Antibodies status (n = 3638) | With Negative Thyroid Antibodies (n = 2931) | ||
|---|---|---|---|---|
Number | Median TSH (2.5–97.5 centiles) | Number | Median TSH (2.5–97.5 centiles) | |
Total population | ||||
18–29 | 660 | 1.82 (0.59–6.12) | 562 | 1.77 (0.61–4.67) |
30–39 | 727 | 1.82 (0.54–5.49) | 600 | 1.72 (0.54–4.68) |
40–49 | 966 | 1.76 (0.47–6.49) | 772 | 1.66 (0.49–4.46) |
50–59 | 740 | 1.84 (0.33–9.27) | 557 | 1.69 (0.43–5.13) |
≥ 60 | 545 | 1.72 (0.39–9.72) | 449 | 1.59 (0.41–6.78) |
All | 3638 | 1.80 (0.47–7.15) | 2931 | 1.69 (0.49–4.87) |
P-value | 0.316 | 0.281 | ||
Males | ||||
18–29 | 140 | 1.70 (0.62–4.81) | 125 | 1.65 (0.67–4.61) |
30–39 | 157 | 1.82 (0.40–5.06) | 132 | 1.79 (0.34–4.91) |
40–49 | 280 | 1.62 (0.54–6.17) | 249 | 1.54 (0.54–4.44) |
50–59 | 259 | 1.62 (0.40–8.72) | 209 | 1.57 (0.40–4.44) |
≥ 60 | 242 | 1.73 (0.32–10.22) | 209 | 1.63 (0.34–6.62) |
All | 1078 | 1.68 (0.47–6.17) | 936 | 1.61 (0.48–4.77) |
P-value | 0.438 | 0.303 | ||
Females | ||||
18–29 | 520 | 1.85 (0.53–6.21) | 437 | 1.80 (0.53–4.75) |
30–39 | 570 | 1.82 (0.54–6.03) | 468 | 1.72 (0.55–4.58) |
40–49 | 686 | 1.83 (0.45–7.51) | 523 | 1.72 (0.47–4.48) |
50–59 | 481 | 1.95 (0.18–9.77) | 336 | 1.81 (0.40–5.52) |
≥ 60 | 303 | 1.67 (0.39–9.27) | 240 | 1.56 (0.41–7.41) |
All | 2560 | 1.84 (0.47–7.54) | 2004 | 1.73 (0.50–4.96) |
P-value | 0.178 | 0.133 | ||